Angiotensin II (human), Vasoconstrictor peptide
4
(1 Review)
|
(27 Publications)
- Available in different sizes to fit your experimental needs
- Cited in over 20 publications
- Chemical Structure
Lab
Chemical Structure - Angiotensin II (human), Vasoconstrictor peptide (AB120183)
2D chemical structure image of ab120183, Angiotensin II (human), Vasoconstrictor peptide
Product details
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Pathways
AGTR1 and AGTR2 interact mainly with the renin-angiotensin-aldosterone system (RAAS) and counter-regulatory pathways like nitric oxide production. AGTR1 activation by angiotensin II influences the RAAS by triggering G-protein signaling cascades leading to the activation of phospholipase C and subsequent inositol triphosphate production. This pathway results in calcium release promoting muscle contraction. AGTR2 can modulate nitric oxide and bradykinin pathways providing vasodilation and antiproliferative effects. Proteins like angiotensin-converting enzyme (ACE) and renin help regulate these pathways through their role in converting angiotensinogen to angiotensin I then to angiotensin II.
Biological function summary
These receptors function distinctly despite both interacting with the angiotensin II peptide. AGTR1 is the major mediator of the angiotensin II-induced vasoconstriction and aldosterone secretion facilitating sodium retention and influencing cardiovascular function. AGTR2 although it binds the same peptide is involved in cellular growth and differentiation displaying roles in neuroprotection and promoting vasodilation. These receptors do not form complexes like ion channels but function independently to fine-tune physiological responses.
Publications (27)
Recent publications for all applications. Explore the full list and refine your search
Clinical and translational medicine 15:e70361 PubMed40468620
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 13:1476329 PubMed40109358
2025
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceuticals (Basel, Switzerland) 17: PubMed39338362
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 81:264 PubMed38878214
2024
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 25:1987-2014 PubMed38454158
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed38397098
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 31:239-253 PubMed38182899
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the American Society of Nephrology : JASN 34:1647-1671 PubMed37725437
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 10:1110707 PubMed37593150
2023
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:12140 PubMed37495624
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com